Milica Cerovic

Milica Cerovic

Auto-generated profile, based on publicly available information

Milica Cerovic

Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Neurobiology of Disease
Verified
Journal Article
Closed access
VIValentina Iori
Valentina Iori
AIAnand M Iyer
Anand M Iyer
TRTeresa Ravizza
Teresa Ravizza
LBLuca Beltrame
Luca Beltrame
LPLara Paracchini
Lara Paracchini
AVAnnamaria Vezzani
Annamaria Vezzani

29 November 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SFStefania Fasano
Stefania Fasano
Erwan BezardErwan Bezard
Erwan Bezard
ADAngela D'Antoni
Angela D'Antoni
Veronica FrancardoVeronica Francardo
Veronica Francardo
MIMarzia Indrigo
Marzia Indrigo
RBRiccardo Brambilla
Riccardo Brambilla
L -dopa–induced dyskinesia (LID) is a common debilitating complication of dopamine replacement therapy in Parkinson's disease. Recent evidence suggests that LID may be linked causally to a hyperactivation of the Ras–ERK signaling cascade in the basal ganglia. We set out to determine whether specific targeting of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1), a brain-specific activator of the Ras–ERK pathway, may provide a therapy for LID. On the rodent abnormal involuntary movements scale, Ras-GRF1–deficient mice were significantly resistant to the development of dyskinesia during chronic l -dopa treatment. Furthermore, in a nonhuman primate model of LID, lentiviral vectors expressing dominant negative forms of Ras-GRF1 caused a dramatic reversion of dyskinesia severity leaving intact the therapeutic effect of l -dopa. These data reveal the central role of Ras-GRF1 in governing striatal adaptations to dopamine replacement therapy and validate a viable treatment for LID based on intracellular signaling modulation.

18 October 2019 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
MCMilica Cerovic
Milica Cerovic
GFGianluigi Forloni
Gianluigi Forloni
CBClaudia Balducci
Claudia Balducci
Alzheimer’s disease (AD) is a complex, multi-factorial disease affecting various brain systems. This complexity implies that successful therapies must be directed against several core neuropathological targets rather than single ones. The scientific community has made great efforts to identify the right AD targets beside the historic amyloid-β (Aβ). Neuroinflammation is re-emerging as determinant in the neuropathological process of AD. A new theory, still in its infancy, highlights the role of gut microbiota (GM) in the control of brain development, but also in the onset and progression of neurodegenerative diseases. Bidirectional communication between the central and the enteric nervous systems, called gut-brain axes, is largely influenced by GM and the immune system is a potential key mediator of this interaction. Growing evidence points to the role of GM in the maturation and activation of host microglia and peripheral immune cells. Several recent studies have found abnormalities in GM (dysbiosis) in AD populations. These observations raise the intriguing question whether and how GM dysbiosis could contribute to AD development through action on the immune system and whether, in a therapeutic prospective, the development of strategies preserving a healthy GM might become a valuable approach to prevent AD. Here, we review the evidence from animal models and humans of the role of GM in neuroinflammation and AD.

8 January 2012 in Nature Neuroscience
Verified
Journal Article
Closed access
CNCristiano Nazzaro
Cristiano Nazzaro
BGBarbara Greco
Barbara Greco
MCMilica Cerovic
Milica Cerovic
PBPaul Baxter
Paul Baxter
TRTiziana Rubino
Tiziana Rubino
RTRaffaella Tonini
Raffaella Tonini

1 March 2018 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
PVPietro La Vitola
Pietro La Vitola
CBClaudia Balducci
Claudia Balducci
MCMilica Cerovic
Milica Cerovic
GSGiulia Santamaria
Giulia Santamaria
EBEdoardo Brandi
Edoardo Brandi
GFGianluigi Forloni
Gianluigi Forloni

1 October 2013 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
MCMilica Cerovic
Milica Cerovic
RDRaffaele d'Isa
Raffaele d'Isa
RTRaffaella Tonini
Raffaella Tonini
RBRiccardo Brambilla
Riccardo Brambilla